Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Prostate Cancer

  Free Subscription


Articles published in J Magn Reson Imaging

Retrieve available abstracts of 76 articles:
HTML format



Single Articles


    May 2021
  1. ZHANG H, Li X, Zhang Y, Huang C, et al
    Diagnostic nomogram based on intralesional and perilesional radiomics features and clinical factors of clinically significant prostate cancer.
    J Magn Reson Imaging. 2021;53:1550-1558.
    PubMed     Abstract available


    April 2021
  2. DWIVEDI DK
    Editorial for "Voxel-level Classification of Prostate Cancer on MRI: Improving Accuracy Using Four-Compartment Restriction Spectrum Imaging".
    J Magn Reson Imaging. 2021 Apr 21. doi: 10.1002/jmri.27646.
    PubMed    


  3. YE Z
    Editorial for "A Deep Learning Approach to Diagnostic Classification of Prostate Cancer Using Pathology-Radiology Fusion".
    J Magn Reson Imaging. 2021 Apr 4. doi: 10.1002/jmri.27630.
    PubMed    


    March 2021
  4. FENG CH, Conlin CC, Batra K, Rodriguez-Soto AE, et al
    Voxel-level Classification of Prostate Cancer on Magnetic Resonance Imaging: Improving Accuracy Using Four-Compartment Restriction Spectrum Imaging.
    J Magn Reson Imaging. 2021 Mar 31. doi: 10.1002/jmri.27623.
    PubMed     Abstract available


  5. RONG R, Hu L
    Editorial for "Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer".
    J Magn Reson Imaging. 2021 Mar 28. doi: 10.1002/jmri.27622.
    PubMed    


  6. KHOSRAVI P, Lysandrou M, Eljalby M, Li Q, et al
    A Deep Learning Approach to Diagnostic Classification of Prostate Cancer Using Pathology-Radiology Fusion.
    J Magn Reson Imaging. 2021 Mar 14. doi: 10.1002/jmri.27599.
    PubMed     Abstract available


  7. CAO R, Zhong X, Afshari S, Felker E, et al
    Performance of Deep Learning and Genitourinary Radiologists in Detection of Prostate Cancer Using 3-T Multiparametric Magnetic Resonance Imaging.
    J Magn Reson Imaging. 2021 Mar 12. doi: 10.1002/jmri.27595.
    PubMed     Abstract available


  8. YAMAMOTO S, Yoshida S, Ishii C, Takahara T, et al
    Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer.
    J Magn Reson Imaging. 2021 Mar 11. doi: 10.1002/jmri.27596.
    PubMed     Abstract available


  9. HAN C, Ma S, Liu X, Liu Y, et al
    Radiomics Models Based on Apparent Diffusion Coefficient Maps for the Prediction of High-Grade Prostate Cancer at Radical Prostatectomy: Comparison With Preoperative Biopsy.
    J Magn Reson Imaging. 2021 Mar 8. doi: 10.1002/jmri.27565.
    PubMed     Abstract available


    February 2021
  10. PARK KJ, Choi SH, Kim MH, Kim JK, et al
    Performance of Prostate Imaging Reporting and Data System Version 2.1 for Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
    J Magn Reson Imaging. 2021 Feb 11. doi: 10.1002/jmri.27546.
    PubMed     Abstract available


    December 2020
  11. VAN NIEUWENHOVE S, Van Damme J, Padhani AR, Vandecaveye V, et al
    Whole-body magnetic resonance imaging for prostate cancer assessment: Current status and future directions.
    J Magn Reson Imaging. 2020 Dec 31. doi: 10.1002/jmri.27485.
    PubMed     Abstract available


    October 2020
  12. BAO J, Zhi R, Hou Y, Zhang J, et al
    Optimized MRI Assessment for Clinically Significant Prostate Cancer: A STARD-Compliant Two-Center Study.
    J Magn Reson Imaging. 2020 Oct 19. doi: 10.1002/jmri.27394.
    PubMed     Abstract available


    July 2020
  13. TAMADA T, Kido A, Yamamoto A, Takeuchi M, et al
    Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
    J Magn Reson Imaging. 2020 Jul 2:e27283. doi: 10.1002/jmri.27283.
    PubMed     Abstract available


    May 2020
  14. PADHANI AR, Schoots I, Villeirs G
    Contrast Medium or No Contrast Medium for Prostate Cancer Diagnosis. That Is the Question.
    J Magn Reson Imaging. 2020 May 3. doi: 10.1002/jmri.27180.
    PubMed     Abstract available


    March 2020
  15. YUAN Q, Pedrosa I
    Editorial for "Luminal Water Imaging: Comparison With Diffusion-Weighted Imaging (DWI) and PI-RADS for Characterization of Prostate Cancer Aggressiveness".
    J Magn Reson Imaging. 2020 Mar 29. doi: 10.1002/jmri.27152.
    PubMed    


  16. GONG L, Xu M, Fang M, Zou J, et al
    Noninvasive Prediction of High-Grade Prostate Cancer via Biparametric MRI Radiomics.
    J Magn Reson Imaging. 2020 Mar 25. doi: 10.1002/jmri.27132.
    PubMed     Abstract available


  17. MOSES DA
    Editorial for "Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques".
    J Magn Reson Imaging. 2020 Mar 19. doi: 10.1002/jmri.27135.
    PubMed    


  18. ZHANG GM, Han YQ, Wei JW, Qi YF, et al
    Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy.
    J Magn Reson Imaging. 2020 Mar 17. doi: 10.1002/jmri.27138.
    PubMed     Abstract available


  19. GALONS JP
    Editorial for "Relative Enhanced Diffusivity in Prostate Cancer: Protocol Optimization and Diagnostic Potential".
    J Magn Reson Imaging. 2020 Mar 5. doi: 10.1002/jmri.27117.
    PubMed    


    February 2020
  20. BYUN J, Park KJ, Kim MH, Kim JK, et al
    Direct Comparison of PI-RADS Version 2 and 2.1 in Transition Zone Lesions for Detection of Prostate Cancer: Preliminary Experience.
    J Magn Reson Imaging. 2020 Feb 11. doi: 10.1002/jmri.27080.
    PubMed     Abstract available


  21. CUI Y, Han S, Liu M, Wu PY, et al
    Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.
    J Magn Reson Imaging. 2020 Feb 6. doi: 10.1002/jmri.27075.
    PubMed     Abstract available


    January 2020
  22. AN JY, Fowler KJ
    Editorial on "Head-to-Head Comparison of PI-RADS Version 2 and 2.1 in Transition Zone Lesions for Detection of Prostate Cancer".
    J Magn Reson Imaging. 2020 Jan 31. doi: 10.1002/jmri.27062.
    PubMed    


  23. HECTORS SJ, Said D, Gnerre J, Tewari A, et al
    Luminal Water Imaging: Comparison With Diffusion-Weighted Imaging (DWI) and PI-RADS for Characterization of Prostate Cancer Aggressiveness.
    J Magn Reson Imaging. 2020 Jan 21. doi: 10.1002/jmri.27050.
    PubMed     Abstract available


    December 2019
  24. QI Y, Zhang S, Wei J, Zhang G, et al
    Multiparametric MRI-Based Radiomics for Prostate Cancer Screening With PSA in 4-10 ng/mL to Reduce Unnecessary Biopsies.
    J Magn Reson Imaging. 2019 Dec 6. doi: 10.1002/jmri.27008.
    PubMed     Abstract available


  25. BILLDAL DC, While PT, Selnaes KM, Sunoqrot MRS, et al
    Relative Enhanced Diffusivity in Prostate Cancer: Protocol Optimization and Diagnostic Potential.
    J Magn Reson Imaging. 2019 Dec 3. doi: 10.1002/jmri.27011.
    PubMed     Abstract available


    November 2019
  26. PEREZ IM, Jambor I, Kauko T, Verho J, et al
    Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials).
    J Magn Reson Imaging. 2019 Nov 21. doi: 10.1002/jmri.26975.
    PubMed     Abstract available


  27. HAUSMANN D, Zoellner FG, Kubik-Huch RA
    Editorial for "Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials)
    J Magn Reson Imaging. 2019 Nov 1. doi: 10.1002/jmri.26980.
    PubMed    


    October 2019
  28. MONTOYA PEREZ I, Jambor I, Pahikkala T, Airola A, et al
    Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques.
    J Magn Reson Imaging. 2019 Oct 6. doi: 10.1002/jmri.26945.
    PubMed     Abstract available


  29. VAN HOUDT PJ, Ghobadi G, Schoots IG, Heijmink SWTPJ, et al
    Histopathological Features of MRI-Invisible Regions of Prostate Cancer Lesions.
    J Magn Reson Imaging. 2019 Oct 6. doi: 10.1002/jmri.26933.
    PubMed     Abstract available


    September 2019
  30. JAMBOR I, Falagario U, Ratnani P, Perez IM, et al
    Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
    J Magn Reson Imaging. 2019 Sep 30. doi: 10.1002/jmri.26928.
    PubMed     Abstract available


    May 2019
  31. GHOLIZADEH N, Greer PB, Simpson J, Fu C, et al
    Supervised risk predictor of central gland lesions in prostate cancer using (1) H MR spectroscopic imaging with gradient offset-independent adiabaticity pulses.
    J Magn Reson Imaging. 2019 May 27. doi: 10.1002/jmri.26803.
    PubMed     Abstract available


  32. BARRETT T, Riemer F, McLean MA, Kaggie JD, et al
    Molecular imaging of the prostate: Comparing total sodium concentration quantification in prostate cancer and normal tissue using dedicated (13) C and (23) Na endorectal coils.
    J Magn Reson Imaging. 2019 May 13. doi: 10.1002/jmri.26788.
    PubMed     Abstract available


  33. MA S, Xie H, Wang H, Han C, et al
    MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer.
    J Magn Reson Imaging. 2019 May 6. doi: 10.1002/jmri.26777.
    PubMed     Abstract available


    April 2019
  34. TONG A, Lemberskiy G, Huang C, Shanbhogue K, et al
    Exploratory study of geometric distortion correction of prostate diffusion-weighted imaging using B0 map acquisition.
    J Magn Reson Imaging. 2019 Apr 16. doi: 10.1002/jmri.26751.
    PubMed     Abstract available


  35. ZANELLI E, Giannarini G, Cereser L, Zuiani C, et al
    Head-to-head comparison between multiparametric MRI, the partin tables, memorial sloan kettering cancer center nomogram, and CAPRA score in predicting extraprostatic cancer in patients undergoing radical prostatectomy.
    J Magn Reson Imaging. 2019 Apr 7. doi: 10.1002/jmri.26743.
    PubMed     Abstract available


    March 2019
  36. MERISAARI H, Jambor I, Ettala O, Bostrom PJ, et al
    IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): Sensitivity for prostate cancer detection in correlation with whole-mount prostatectomy sections and implications for focal therapy.
    J Magn Reson Imaging. 2019 Mar 22. doi: 10.1002/jmri.26727.
    PubMed     Abstract available


    February 2019
  37. SUNG K
    Modified MR dispersion imaging in prostate dynamic contrast-enhanced MRI.
    J Magn Reson Imaging. 2019 Feb 17. doi: 10.1002/jmri.26685.
    PubMed     Abstract available


  38. STEPHEN EVANS V, Torrealdea F, Rega M, Brizmohun Appayya M, et al
    Optimization and Repeatability of Multipool Chemical Exchange Saturation Transfer MRI of the Prostate at 3.0 T.
    J Magn Reson Imaging. 2019 Feb 15. doi: 10.1002/jmri.26690.
    PubMed     Abstract available


    January 2019
  39. WU M, Krishna S, Thornhill RE, Flood TA, et al
    Transition zone prostate cancer: Logistic regression and machine-learning models of quantitative ADC, shape and texture features are highly accurate for diagnosis.
    J Magn Reson Imaging. 2019 Jan 30. doi: 10.1002/jmri.26674.
    PubMed     Abstract available


  40. PRABHU V, Rosenkrantz AB, Otazo R, Sodickson DK, et al
    Population net benefit of prostate MRI with high spatiotemporal resolution contrast-enhanced imaging: A decision curve analysis.
    J Magn Reson Imaging. 2019 Jan 10. doi: 10.1002/jmri.26318.
    PubMed     Abstract available


    December 2018
  41. CARLIN D, Orton MR, Collins D, deSouza NM, et al
    Probing structure of normal and malignant prostate tissue before and after radiation therapy with luminal water fraction and diffusion-weighted MRI.
    J Magn Reson Imaging. 2018 Dec 27. doi: 10.1002/jmri.26597.
    PubMed     Abstract available


  42. DINIS FERNANDES C, van Houdt PJ, Heijmink SWTPJ, Walraven I, et al
    Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external-beam radiation therapy.
    J Magn Reson Imaging. 2018 Dec 25. doi: 10.1002/jmri.26581.
    PubMed     Abstract available


  43. DEVINE W, Giganti F, Johnston EW, Sidhu HS, et al
    Simplified Luminal Water Imaging for the Detection of Prostate Cancer From Multiecho T2 MR Images.
    J Magn Reson Imaging. 2018 Dec 19. doi: 10.1002/jmri.26608.
    PubMed     Abstract available


  44. MOULOPOULOS LA, Koutoulidis V
    Whole-Body MRI of the Bone Marrow: Reporting.
    J Magn Reson Imaging. 2018 Dec 12. doi: 10.1002/jmri.26595.
    PubMed    


  45. YOON YI, Ha SW, Lee HJ
    An ultrasound-responsive dual-modal US/T1 -MRI contrast agent for potential diagnosis of prostate cancer.
    J Magn Reson Imaging. 2018;48:1610-1616.
    PubMed     Abstract available


    November 2018
  46. BROEKE NC, Peterson J, Lee J, Martin PA, et al
    Characterization of clinical human prostate cancer lesions using 3.0-T sodium MRI registered to Gleason-graded whole-mount histopathology.
    J Magn Reson Imaging. 2018 Nov 14. doi: 10.1002/jmri.26336.
    PubMed     Abstract available


    October 2018
  47. STEENSMA BR, Luttje M, Voogt IJ, Klomp DWJ, et al
    Comparing signal-to-noise ratio for prostate imaging at 7T and 3T.
    J Magn Reson Imaging. 2018 Oct 22. doi: 10.1002/jmri.26527.
    PubMed     Abstract available


  48. WANG S, Fan X, Yousuf A, Eggener SE, et al
    Evaluation of Focal Laser Ablation of Prostate Cancer Using High Spectral and Spatial Resolution Imaging: A Pilot Study.
    J Magn Reson Imaging. 2018 Oct 6. doi: 10.1002/jmri.26538.
    PubMed     Abstract available


    September 2018
  49. CHEN T, Li M, Gu Y, Zhang Y, et al
    Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    J Magn Reson Imaging. 2018 Sep 19. doi: 10.1002/jmri.26243.
    PubMed     Abstract available


  50. GIROMETTI R, Giannarini G, Greco F, Isola M, et al
    Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.
    J Magn Reson Imaging. 2018 Sep 5. doi: 10.1002/jmri.26220.
    PubMed     Abstract available


  51. ZHANG Z, Xu H, Xue Y, Li J, et al
    Risk Stratification of Prostate Cancer Using the Combination of Histogram Analysis of Apparent Diffusion Coefficient Across Tumor Diffusion Volume and Clinical Information: A Pilot Study.
    J Magn Reson Imaging. 2018 Sep 2. doi: 10.1002/jmri.26235.
    PubMed     Abstract available


    August 2018
  52. WU HH, Priester A, Khoshnoodi P, Zhang Z, et al
    A system using patient-specific 3D-printed molds to spatially align in vivo MRI with ex vivo MRI and whole-mount histopathology for prostate cancer research.
    J Magn Reson Imaging. 2018 Aug 2. doi: 10.1002/jmri.26189.
    PubMed     Abstract available


    May 2018
  53. SHIRADKAR R, Ghose S, Jambor I, Taimen P, et al
    Radiomic features from pretreatment biparametric MRI predict prostate cancer biochemical recurrence: Preliminary findings.
    J Magn Reson Imaging. 2018 May 7. doi: 10.1002/jmri.26178.
    PubMed     Abstract available


    April 2018
  54. SONG Y, Zhang YD, Yan X, Liu H, et al
    Computer-aided diagnosis of prostate cancer using a deep convolutional neural network from multiparametric MRI.
    J Magn Reson Imaging. 2018 Apr 16. doi: 10.1002/jmri.26047.
    PubMed     Abstract available


    March 2018
  55. GAUR S, Harmon S, Mehralivand S, Bednarova S, et al
    Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer.
    J Magn Reson Imaging. 2018 Mar 31. doi: 10.1002/jmri.26025.
    PubMed     Abstract available


  56. LUZURIER A, Jouve De Guibert PH, Allera A, Feldman SF, et al
    Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.
    J Magn Reson Imaging. 2018 Mar 8. doi: 10.1002/jmri.25991.
    PubMed     Abstract available


    February 2018
  57. ALGOHARY A, Viswanath S, Shiradkar R, Ghose S, et al
    Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings.
    J Magn Reson Imaging. 2018 Feb 22. doi: 10.1002/jmri.25983.
    PubMed     Abstract available


  58. WANG J, Wu CJ, Bao ML, Zhang J, et al
    Using support vector machine analysis to assess PartinMR: A new prediction model for organ-confined prostate cancer.
    J Magn Reson Imaging. 2018 Feb 13. doi: 10.1002/jmri.25961.
    PubMed     Abstract available


  59. LIU W, Liu XH, Tang W, Gao HB, et al
    Histogram analysis of stretched-exponential and monoexponential diffusion-weighted imaging models for distinguishing low and intermediate/high gleason scores in prostate carcinoma.
    J Magn Reson Imaging. 2018 Feb 7. doi: 10.1002/jmri.25958.
    PubMed     Abstract available


    January 2018
  60. SILLERUD LO
    Quantitative [Fe]MRI determination of the dynamics of PSMA-targeted SPIONs discriminates among prostate tumor xenografts based on their PSMA expression.
    J Magn Reson Imaging. 2018 Jan 13. doi: 10.1002/jmri.25935.
    PubMed     Abstract available


    November 2017
  61. GIGANTI F, Gambarota G, Moore CM, Robertson NL, et al
    Prostate cancer detection using quantitative T2 and T2 -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance.
    J Magn Reson Imaging. 2017 Nov 14. doi: 10.1002/jmri.25891.
    PubMed     Abstract available


    September 2017
  62. YIM JH, Kim CK, Kim JH
    Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.
    J Magn Reson Imaging. 2017 Sep 13. doi: 10.1002/jmri.25856.
    PubMed     Abstract available


  63. DWIVEDI DK, Kumar R, Dwivedi AK, Bora GS, et al
    Prebiopsy multiparametric MRI-based risk score for predicting prostate cancer in biopsy-naive men with prostate-specific antigen between 4-10 ng/mL.
    J Magn Reson Imaging. 2017 Sep 4. doi: 10.1002/jmri.25850.
    PubMed     Abstract available


    June 2017
  64. HEIDKAMP J, Hoogenboom M, Kovacs IE, Veltien A, et al
    Ex vivo MRI evaluation of prostate cancer: Localization and margin status prediction of prostate cancer in fresh radical prostatectomy specimens.
    J Magn Reson Imaging. 2017 Jun 5. doi: 10.1002/jmri.25785.
    PubMed     Abstract available


    April 2017
  65. KRISHNA S, Lim CS, McInnes MD, Flood TA, et al
    Evaluation of MRI for diagnosis of extraprostatic extension in prostate cancer.
    J Magn Reson Imaging. 2017 Apr 7. doi: 10.1002/jmri.25729.
    PubMed     Abstract available


  66. HELFRICH O, Puech P, Betrouni N, Pincon C, et al
    Quantified analysis of histological components and architectural patterns of gleason grades in apparent diffusion coefficient restricted areas upon diffusion weighted MRI for peripheral or transition zone cancer locations.
    J Magn Reson Imaging. 2017 Apr 6. doi: 10.1002/jmri.25716.
    PubMed     Abstract available


    March 2017
  67. STRAUB S, Laun FB, Emmerich J, Jobke B, et al
    Potential of quantitative susceptibility mapping for detection of prostatic calcifications.
    J Magn Reson Imaging. 2017;45:889-898.
    PubMed     Abstract available


    February 2017
  68. WEISS J, Martirosian P, Taron J, Othman AE, et al
    Feasibility of accelerated simultaneous multislice diffusion-weighted MRI of the prostate.
    J Magn Reson Imaging. 2017 Feb 15. doi: 10.1002/jmri.25665.
    PubMed     Abstract available


    January 2017
  69. SABOURI S, Fazli L, Chang SD, Savdie R, et al
    MR measurement of luminal water in prostate gland: Quantitative correlation between MRI and histology.
    J Magn Reson Imaging. 2017 Jan 27. doi: 10.1002/jmri.25624.
    PubMed     Abstract available


  70. HECTORS SJ, Besa C, Wagner M, Jajamovich GH, et al
    DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
    J Magn Reson Imaging. 2017 Jan 16. doi: 10.1002/jmri.25631.
    PubMed     Abstract available


    November 2016
  71. LIM CS, McInnes MD, Lim RS, Breau RH, et al
    Prognostic value of Prostate Imaging and Data Reporting System (PI-RADS) v. 2 assessment categories 4 and 5 compared to histopathological outcomes after radical prostatectomy.
    J Magn Reson Imaging. 2016 Nov 3. doi: 10.1002/jmri.25539.
    PubMed     Abstract available


    October 2016
  72. PARK JJ, Park BK
    Role of PI-RADSv2 with multiparametric MRI in determining who needs active surveillance or definitive treatment according to PRIAS.
    J Magn Reson Imaging. 2016 Oct 26. doi: 10.1002/jmri.25534.
    PubMed     Abstract available


    August 2016
  73. WEIS J, von Below C, Tolf A, Ortiz-Nieto F, et al
    Quantification of metabolite concentrations in benign and malignant prostate tissues using 3D proton MR spectroscopic imaging.
    J Magn Reson Imaging. 2016 Aug 24. doi: 10.1002/jmri.25443.
    PubMed     Abstract available


  74. BRUNSING RL, Schenker-Ahmed NM, White NS, Parsons JK, et al
    Restriction spectrum imaging: An evolving imaging biomarker in prostate MRI.
    J Magn Reson Imaging. 2016 Aug 16. doi: 10.1002/jmri.25419.
    PubMed     Abstract available


    July 2016
  75. AGARWAL HK, Mertan FV, Sankineni S, Bernardo M, et al
    Optimal high b-value for diffusion weighted MRI in diagnosing high risk prostate cancers in the peripheral zone.
    J Magn Reson Imaging. 2016 Jul 7. doi: 10.1002/jmri.25353.
    PubMed     Abstract available


    June 2016
  76. GINSBURG SB, Taimen P, Merisaari H, Vainio P, et al
    Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
    J Magn Reson Imaging. 2016 Jun 10. doi: 10.1002/jmri.25330.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: